MedWatch

Novo Nordisk gearing up for launches

The Danish insulin giant, Novo Nordisk, expects to launch six to eight new drugs before 2016. Read on to see which.

A great round of drug launches is underway in the Danish pharmaceutical group Novo Nordisk. One of those drugs is the long-acting diabetes drug Tresiba, a project that is headed by 46-year-old Jakob Riis.

He has transformed the marketing function in Novo Nordisk, so his department for Global Marketing and Medical Affairs is now a central part of Novo Nordisk’s commercial function, according to Berlingske Business.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier